JAMA Editors' Summary Higher-Dose Ivermectin for Outpatients With COVID-19, Trends in Cardiovascular Risk Factor Prevalence and Control in US Adults, Review of Chronic Lymphocytic Leukemia, and more
Mar 21, 2023
Chapters
Transcript
Episode notes
